CS1, also known as CD319, SLAMF7, and CRACC, is a cell surface glycoprotein, which is highly expressed on multiple myeloma (MM) cells both at diagnosis and at relapse [1]. Here, SLAMF7 is linked to Miyoshi myopathy.